Pharmafile Logo
Pharmafocus logo
Advanced Search

monsanto

Showing 15 posts of 15 posts found.

Bayer to cut 12,000 jobs by 2025

December 6, 2018
Business Services, Manufacturing and Production, Sales and Marketing Bayer, Germany, Jobs, manfucaturing, monsanto, production

German pharma giant Bayer is set to cut 12,000 jobs by 2025 as part of a plan to focus on …

News

Bayer announces major restructure, 12,000 jobs to go

November 30, 2018
Medical Communications, Sales and Marketing Bayer, job cuts, monsanto, pharma

Bayer has announced a major restructure of its operations in 2019 which will see the loss of 12,000 of its …

News
bayer_cross_2

Bayer eyes R&D cuts, as Monsanto deal raises question of focus

June 1, 2018
Medical Communications Bayer, biotech, drugs, monsanto, pharma, pharmaceutical

When rumours first started rumbling about a mega-merger between Bayer and Monsanto, one of the major question marks was on …

News
bayer_cross_2

Bayer-Monsanto deal one step closer, after EU nod

March 22, 2018
Sales and Marketing Bayer, EU, biotech, drugs, monsanto, pharma, pharmaceutical

The merger between Bayer and agricultural giant, Monsanto, is inching closer to completion after the EU Commission won EU antitrust …

News
money-256281_960_720

Five most talked about mergers and acquisitions of 2016

January 27, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Actavis, Bayer, Boehringer, Johnson & Johnson, Sanofi, Teva, acquisition, mergers, monsanto, pharma

2017 has kicked off with a bang – as Johnson & Johnson confirmed a $30 billion deal to takeover of …

Feature

Looking back at the biggest deal of 2016: Bayer-Monsanto

December 2, 2016
Medical Communications Bayer, acquisition, big deal, monsanto, pharma deal 2016

The industry followed Bayer’s attempts to acquire US agricultural firm Monsanto with fevered anticipation; the takeover eventually closed in September …

News

Bayer CEO defends $66 billion Monsanto acquisition

September 20, 2016
Manufacturing and Production, Sales and Marketing Bayer, Werner Baumann, monsanto

Bayer AG’s chief executive Werner Baumann has spoken in defence of the company’s move last week to acquire US agricultural …

News
4420456374_64a3d7e6aa

Top Ten articles in the Pharma Industry this week

September 16, 2016
Medical Communications Bayer, GSK, Gilead, GlaxoSmithKline, J&J, JJ, Pfizer, Roche, Sanofi, Takeda, aspen, google, monsanto

As we come to the end of another week, we’re looking back at an exciting week in the industry; there …

News

Bayer acquires Monsanto in largest-ever deal by a German company

September 14, 2016
Business Services, Manufacturing and Production, Sales and Marketing Bayer, acqusition, monsanto

Bayer and Monsanto have signed a definitive merger agreement under which the German drugmaker will acquire the US agricultural group …

News

Bayer ponders $1.1 billion portfolio sale to fund Monsanto acquisition

September 12, 2016
Business Services, Manufacturing and Production, Sales and Marketing Bayer, acquisition, monsanto

In the latest development in the Bayer-Monsanto saga, the German drugmaker has enlisted the aid of global financial services firm …

News

Bayer takes another shot at Monsanto acquisition

September 6, 2016
Manufacturing and Production, Sales and Marketing Bayer, acqusition, monsanto

Bayer has made another move to acquire US-based Monsanto, raising the price it is prepared to pay in an effort …

News

Bayer adds extra $2 billion to Monsanto bid

July 15, 2016
Medical Communications, Sales and Marketing Bayer, monsanto

German pharma company Bayer (ETR: BAYN) have upped their bid for Monsanto (NYSE: MON) to $64 billion, putting pressure on …

News

Monsanto rejects Bayer’s $62 billion offer

May 25, 2016
Business Services, Research and Development, Sales and Marketing Bayer, Financial, M&A, MA, deal, monsanto

World’s largest seed maker Monsanto (NYSE: MON) has rejected the $62 billion takeover offer from Germany’s Bayer AG (ETR: BAYN) …

News

Bayer offers $62 billion for Monsanto in all cash deal

May 23, 2016
Research and Development, Sales and Marketing Bayer, Deals, Financial, Merger & Acquisition, monsanto

German pharma and crop sciences giant Bayer (ETR: BAYN) has made an unsolicited $62 billion all-cash offer for Monsanto Co …

News

Bayer makes bid for Monsanto

May 19, 2016
Manufacturing and Production, Sales and Marketing Bayer, agrochemical, bid, monsanto, takeover

Bayer (ETR: BAYN) has made a move to consolidate its position in the agrochemical sector with an unsolicited takeover bid …

News

Latest content

Austrian state secretary to speak at FlyPharma Europe 2023

September 29, 2023

Karuna Therapeutics submits NDA to FDA for schizophrenia treatment

September 29, 2023

Kura Oncology shares preclinical data for NSCLC treatment

September 29, 2023

BactiVac funds development of bacterial vaccines to prevent infections against antimicrobial resistance

September 28, 2023

Avalyn Pharma raises $175m in Series C financing for inhalation therapies

September 28, 2023